References
- 1. Atlee JL. Complications in Aanesthesia. Philadelphia: Saunders Elsevier; 2007.
- 2. Burns A, Iliffe S. Alzheimer’s disease. BMJ. 2009;338:b158.10.1136/bmj.b158
- 3. Perry EK, Tomlinson BE, Blessed G, Bergmann K, Gibson PH, Perry RH. Correlation of cholinergic abnormalities with senile plaques and mental test scores in senile dementia. Br Med J. 1978;2(6150):1457-9.10.1136/bmj.2.6150.1457
- 4. Perry EK, Walker M, Grace J, Perry RH. Acetylcholine in mind: a neurotransmitter correlate of consciousness? Trends Neurosci. 1999; 22(6):273-80.10.1016/S0166-2236(98)01361-7
- 5. Draczkowski P, Tomaszuk A, Halczuk P, Strzemski M, Matosiuk D, Jozwiak K. Determination of affinity and efficacy of acetylcholinesterase inhibitors using isothermal titration calorimetry. Biochim Biophys Acta Gen Subj. 2016;1860(5):967-74.10.1016/j.bbagen.2015.11.00626586471
- 6. Dhanjal JK, Sharma S, Grover A, Das A. Use of ligand-based pharmacophore modeling and docking approach to find novel acetylcholinesterase inhibitors for treating Alzheimer’s. Biomed Pharmacother. 2015;71:146-52.10.1016/j.biopha.2015.02.01025960230
- 7. Chigurupati S, Selvaraj M, Mani V, Selvarajan KK, Mohammad JI, Kaveti B, et al. Identification of novel acetylcholinesterase inhibitors: indolopyrazoline derivatives and molecular docking studies. Bioorg Chem. 2016;67:9-17.10.1016/j.bioorg.2016.05.00227231830
- 8. Lane RM, Kivipelto M, Greig NH. Acetylcholinesterase and its inhibition in Alzheimer disease. Clin Neuropharmacol. 2004;27:141-9.10.1097/00002826-200405000-0001115190239
- 9. Galisteo M, Rissel M, Sergent O, Chevanne M, Cillard J, Guillouzo A, et al. Hepatotoxicity of tacrine: occurrence of membrane fluidity alterations without involvement of lipid peroxidation. J Pharmacol Exp Ther. 2000;294:160-7.
- 10. Birks J. Cholinesterase inhibitors for Alzheimer’s disease. Cochrane Db Syst Rev. 2006;1:CD005593.10.1002/14651858.CD005593900634316437532
- 11. Alldredge KB. Applied therapeutics: The clinical use of drugs. 10th ed. Baltimore: Wolters Kluwer Health/Lippincott Williams & Wilkins; 2013.
- 12. Chitranshi N, Gupta S, Tripathi PK, Seth PK. New molecular scaffolds for the design of Alzheimer’s acetylcholinesterase inhibitors identified using ligand- and receptor-based virtual screening. Med Chem Res. 2013;2:2328-45.10.1007/s00044-012-0227-3
- 13. Quinn DM. Acetylcholinesterase: Enzyme structure, reaction dynamics, and virtual transition states. Chem Rev. 1987;87:955-75.10.1021/cr00081a005
- 14. Szegletes T, Mallender WD, Thomas PJ, Rosenberry TL. Substrate binding to the peripheral site of acetylcholinesterase initiates enzymatic catalysis. Substrate inhibition arises as a secondary effect. Biochemistry. 1999;38:122-33.10.1021/bi98135779890890
- 15. Bourne Y, Taylor P, Radic Z, Marchot P. Structural insights into ligand interactions at the acetylcholinesterase peripheral anionic site, EMBO J. 2003;22:1-12.10.1093/emboj/cdg005
- 16. Dvir H, Silman I, Harel M, Rosenberry TL, Sussman JL. Acetylcholinesterase: From 3D structure to function. Chem Biol Interact. 2010;187:10-22.10.1016/j.cbi.2010.01.042289430120138030
- 17. Stahura FL, Bajorath J. Virtual screening methods that complement HTS. Comb Chem High Throughput Screen. 2004; 7:259-69.10.2174/138620704332870615200375
- 18. Cheung J, Gary EN, Shiomi K, Rosenberry TL. Structures of human acetylcholinesterase bound to dihydrotanshinone I and territrem B show peripheral site flexibility. ACS Med Chem Lett. 2013;11:1091-6.10.1021/ml400304w402715224900610
- 19. Lipinski CA, Lombardo F, Dominy BW, Feeney PJ. Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. Adv Drug Deliv Rev. 2001:46:3-26.
- 20. Grosdidier A. Conception d’un logiciel de docking et applications dans la recherche de nouvelles molécules actives. PhD Thesis : Joseph Fourier University, France; 2007.
- 21. Beri V, Wildman SA, Shiomi K, Al-Rashid Z, Cheung J, Rosenberry TL. The natural product dihydrotanshinone I provides a prototype for uncharged inhibitors that bind specifically to the acetylcholinesterase peripheral site with nanomolar affinity. Biochem. 2013; 52: 7486-99.10.1021/bi401043w24040835